The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.
April 17th 2024
Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders.
Postdischarge Telemonitoring, Telephone Coaching May Benefit Certain Patients With Heart Failure
February 17th 2023Patients with heart failure and high comorbidity burdens who received postdischarge noninvasive telemonitoring and nurse telephone coaching showed better survival outcomes than those who received standard care.
Read More
Dr Michael Portman Illuminates the Differences Between Pediatric, Adult Anticoagulation Studies
January 23rd 2023Pharmaceutical companies would have to spend a lot of money on pediatric anticoagulation studies for diseases that are rare among these patients, explained Michael A. Portman, MD, FAHA, of Seattle Children's Hospital.
Watch
Dr Michael Portman Explains How Cardiac Disease Differs Between Pediatric, Adult Patients
January 16th 2023During an interview at the 2022 American Heart Association Scientific Sessions in Chicago, Michael A. Portman, MD, FAHA, Seattle Children's Hospital addressed how cardiac disease presents in pediatric vs adult patients.
Watch
Dr Michael Paull Highlights the Vancouver Clinic's Progress With Hypertension Metrics
January 10th 2023Michael Paull, MD, medical director of primary/urgent care and continuous improvement at the Vancouver Clinic (TVC), explained how TVC was able to improve its hypertension metrics to align with CMS' targets.
Watch
Sacubitril/Valsartan Safe, Effective for Patients With HFpEF Undergoing MHD
January 6th 2023The efficacy and safety of sacubitril/valsartan, the angiotensin receptor neprilysin inhibitor, was investigated among a patient population who had heart failure with preserved ejection fraction (HFpEF) and currently receiving maintenance hemodialysis (MHD).
Read More
ICYMI: Highlights From the 2022 AHA Scientific Sessions
December 15th 2022At this year’s American Heart Association (AHA) Scientific Sessions, held November 5-7 in Chicago, Illinois, hot topics for discussion included VICTORIA trial data and the great need for new antihypertensive agents to reduce health care disparities.
Read More
Dr Douglas Mann on Next Steps to Studying Gene Editing in Heart Failure
December 9th 2022Initial data on NTLA-2001, which is a novel investigative intravenous agent that works to prevent development of cardiac transthyretin (ATTR) amyloidosis by targeting the TTR gene and TTR protein levels, were presented at this year’s American Heart Association’s Scientific Sessions in Chicago.
Watch
ICYMI: Top Highlights From ACC 2022
December 8th 2022The American College of Cardiology’s 71st Scientific Session covered how to address the impact of social determinants of health on cardiovascular outcomes, understanding the latest developments in digital health, and the role of COVID-19 on heart health.
Read More
Care Fragmentation Predicts 90-Day Durable Ventricular Assist Device Outcomes
This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.
Read More
Potential for ICI-Related Arrhythmias Necessitates Recognizing Risk Early
November 29th 2022Researchers pulled data from the FDA’s Adverse Event Reporting System to analyze cardiac arrhythmia–related outcomes among patients on a mono or combination regimen for cancer treatment that included immune checkpoint inhibitors (ICIs).
Read More
Dr Tochi Okwuosa: There Is a Great Need for Better CVD Risk Prediction in Cardio-Oncology
November 19th 2022In an interview at this year’s American Heart Association Scientific Sessions meeting in Chicago, Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical Center, discussed the importance of addressing cardiovascular disease (CVD) prevention in patients with cancer who are undergoing treatment.
Watch
Sacubitril/Valsartan Linked to Improved Cardiac Autonomic Nervous System in HFrEF
November 15th 2022This international study, from investigators in Germany and Austria, looked at the effect sacubitril/valsartan can have among patients who have heart failure with reduced ejection fraction (HFrEF) and the impact on their cardiac autonomic nervous system.
Read More
Dr Amresh Raina Addresses Gender Differences in HF Presentation
November 12th 2022Disease symptomatology may be the same, but the presentation of heart failure (HF) and heart attacks differ between women and men, explained Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Watch
Comorbid Septic Shock, HFrEF Linked to Lack of Guideline-Recommended Treatment
November 10th 2022Patients with heart failure frequently suffer from fluid overload, and for those with heart failure with reduced ejection fraction (HFrEF) also suffering from septic shock—a condition often treated with fluids—more data are needed on outcomes following fluid administration.
Read More
Dr Amresh Raina Illuminates Top Concerns in Asymptomatic Heart Failure
November 1st 2022Risk factors not properly addressed in patients with asymptomatic heart failure, such as high blood pressure and having diabetes or mild heart valve problems, can lead to structural heart problems or heart failure itself, noted Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Watch
Increasing HF-Related Mortality Concerning Among Young Adults, Experts Say
October 26th 2022The limited data on heart failure (HF)-related mortality among young adults, those aged 15 to 44 years, prompted this analysis of data from 1999 to 2019 that considered HF as a contributing or underlying cause of death.
Read More
Black Patients’ Uptake of Advanced HF Treatments Falls Behind That of White Patients
October 21st 2022Despite known racial disparities in access to advanced heart failure (HF) treatments, the reasons for this continue to require further exploration. In this new study, investigators searched for associations between ventricular assist device use and heart transplant and race (Black or White).
Read More
Dr Amresh Raina Explains Radiation’s Impact on the Heart
October 19th 2022There is potential impact on the heart, coronary arteries, and heart function following radiation to the left side of the body, explained Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania.
Watch